Enrolling by invitationNCT07003256

Observational Study: Romiplostim for Platelet Recovery in Haploidentical HSCT

Studying Genetic hemoglobinopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
Principal Investigator
Xiaoyang Yang, MD, MD, MPH
Department of Hematology, Haikou People's Hospital
Intervention
Romiplostim(drug)
Enrollment
30 enrolled
Eligibility
2-17 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07003256 on ClinicalTrials.gov

Other trials for Genetic hemoglobinopathy

Additional recruiting or active studies for the same condition.

See all trials for Genetic hemoglobinopathy

← Back to all trials